Akorn has named Christopher Young as its executive vice-president of global operations, reporting to president and chief executive officer (CEO) Doug Boothe. The US-based injectables and ophthalmics specialist has also added two new members to its board.
With 25 years of pharmaceutical experience, Young most recently served as the executive vice-president of global operations for Alvogen. Prior...




